中华耳鼻咽喉头颈外科杂志
中華耳鼻嚥喉頭頸外科雜誌
중화이비인후두경외과잡지
CHINESE JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY
2009年
5期
381-384
,共4页
魏明辉%唐平章%徐震纲%祁永发%殷玉林
魏明輝%唐平章%徐震綱%祁永髮%慇玉林
위명휘%당평장%서진강%기영발%은옥림
癌,腺样囊性%鼻窦肿瘤%综合疗法%预后
癌,腺樣囊性%鼻竇腫瘤%綜閤療法%預後
암,선양낭성%비두종류%종합요법%예후
Carcinoma,adenoid cystic%Paranasal sinus neoplasms%Combined modality therapy%Prognosis
目的 总结鼻腔鼻窦腺样囊性癌的临床特点及治疗方法,对其预后及影响因素进行分析.方法 回顾性分析中国医学科学院肿瘤医院1994-2003年40例鼻腔鼻窦腺样囊性癌患者临床资料,采用Kaplan-Meier法和Log-rank检验分析其生存率、复发及远处转移特点.结果 鼻腔鼻窦腺样囊性癌原发于上颌窦者最多见,占80%.全部患者5年及10年生存率分别为76.9%和61.6%;5年和10年的无瘤生存率分别为44.2%和23.0%.5年复发率及远处转移率分别为45.0%和23.0%.肺转移是远处转移的主要方式,远处转移的出现和生存率下降密切相关(χ2=7.26,P=0.007).术前放疗患者远处转移发生率(18.2%)低于术后放疗者(38.9%),但差异无统计学意义(χ2=1.37,P=0.24).对复发患者采取以手术治疗为主的综合治疗,复发后5年生存率为60.0%.结论 远处转移可能是影响患者预后的重要因素;手术+放疗的综合治疗是治疗腺样囊性癌的主要治疗方式,放疗在鼻腔鼻窦腺样囊性癌的治疗中有重要作用;积极采取以手术为主的综合治疗方式,可有效延长复发患者的生存期,提高生存率.
目的 總結鼻腔鼻竇腺樣囊性癌的臨床特點及治療方法,對其預後及影響因素進行分析.方法 迴顧性分析中國醫學科學院腫瘤醫院1994-2003年40例鼻腔鼻竇腺樣囊性癌患者臨床資料,採用Kaplan-Meier法和Log-rank檢驗分析其生存率、複髮及遠處轉移特點.結果 鼻腔鼻竇腺樣囊性癌原髮于上頜竇者最多見,佔80%.全部患者5年及10年生存率分彆為76.9%和61.6%;5年和10年的無瘤生存率分彆為44.2%和23.0%.5年複髮率及遠處轉移率分彆為45.0%和23.0%.肺轉移是遠處轉移的主要方式,遠處轉移的齣現和生存率下降密切相關(χ2=7.26,P=0.007).術前放療患者遠處轉移髮生率(18.2%)低于術後放療者(38.9%),但差異無統計學意義(χ2=1.37,P=0.24).對複髮患者採取以手術治療為主的綜閤治療,複髮後5年生存率為60.0%.結論 遠處轉移可能是影響患者預後的重要因素;手術+放療的綜閤治療是治療腺樣囊性癌的主要治療方式,放療在鼻腔鼻竇腺樣囊性癌的治療中有重要作用;積極採取以手術為主的綜閤治療方式,可有效延長複髮患者的生存期,提高生存率.
목적 총결비강비두선양낭성암적림상특점급치료방법,대기예후급영향인소진행분석.방법 회고성분석중국의학과학원종류의원1994-2003년40례비강비두선양낭성암환자림상자료,채용Kaplan-Meier법화Log-rank검험분석기생존솔、복발급원처전이특점.결과 비강비두선양낭성암원발우상합두자최다견,점80%.전부환자5년급10년생존솔분별위76.9%화61.6%;5년화10년적무류생존솔분별위44.2%화23.0%.5년복발솔급원처전이솔분별위45.0%화23.0%.폐전이시원처전이적주요방식,원처전이적출현화생존솔하강밀절상관(χ2=7.26,P=0.007).술전방료환자원처전이발생솔(18.2%)저우술후방료자(38.9%),단차이무통계학의의(χ2=1.37,P=0.24).대복발환자채취이수술치료위주적종합치료,복발후5년생존솔위60.0%.결론 원처전이가능시영향환자예후적중요인소;수술+방료적종합치료시치료선양낭성암적주요치료방식,방료재비강비두선양낭성암적치료중유중요작용;적겁채취이수술위주적종합치료방식,가유효연장복발환자적생존기,제고생존솔.
Objective To study the clinical characters and the mode of treatment, and to analyze the prognosis of patients with sinonasal adenoid cystic carcinoma. Methods The clinical data were analyzed retrospectively in 40 patients with sinonasal adenoid cystic carcinoma. The characters of survival rate, local recurrence and distant metastasis in these patients were analyzed using Kaplan-Meier method and Log-rank test. Results The maxillary sinus was the most common site of origin and account for 80% of all patients. Five-year and ten-year overall survival rate were 76.9% and 61.6% respectively. Five-year and ten-year disease-free survival rate were 44. 2% and 23.0%. Five-year local recurrence rate and distant metastasis rate were 45.0% and 23.0%, respectively. The most common site of distant metastasis was lung. Presence of distant metastasis correlated with decreased 5-year survival (χ2= 7.26, P = 0.007). The distant metastasis rate of preoperative treatment (18.2%) seemed lower than that of postoperative treatment (38. 9%), but there was no significant difference in the two groups (χ2 = 1.37, P = 0.24). The combined therapy mainly composed of surgery was adopted to treat the local recurrence. Five-year survival rate after development of local recurrence was 60. 0%. Conclusions Distant metastasis is an important factor affecting the prognosis of the patients with sinonasal adenoid cystic carcinoma. Combined therapy composed of surgery and radiation was the first choice of treatment to the patients with sinonasal adenoid cystic carcinoma. Radiation can play an important role in the treatment. The combined therapy mainly composed of surgery should be adopted in the patients with local recurrence to improve the survival rate.